Continuous progress in life-sciences, medicine and biotechnology has provided us access to new ways to treat, prevent and even cure human diseases. These rapid advancements raised complex ethical and safety issues requiring us to reexamine our traditional moral views.
Matters are additionally complicated by the moral dilemmas which characterize some recent developments: cloning, reproductive technologies, regenerative medicine, and gene therapy, among others.
As the impact of these advancements on individuals, communities and societies grows, so does the importance of Bioethics, a field which emerged about fifty years ago. Through both a theoretical and a practical endeavor, Bioethics allows us to discuss and understand our deep moral concerns, fears and hopes regarding the impact of medical sciences and biotechnological advancements on our lives.
Global Bioethics Initiative (GBI) is a tax-exempt 501(c)(3) international, non-profit organization co-founded in 2011 by Ana Lita, Ph.D. and Charles Debrovner, M.D.
Global Bioethics Initiative (GBI) is dedicated to fostering public awareness and understanding of bioethical issues, as well as to exploring solutions to bioethical challenges.
1. Human organ transplantation and trafficking
2. Ethical issues surrounding End-of-Life
3. Ethical issues related to Assisted Reproductive Technologies (ART)
4. Regenerative medicine and healthy aging
GBI organizes periodic focus groups, workshops, panel discussions, and conferences to facilitate public understanding of current bioethical issues impacting us all. For information about events click here.
GBI leverages the knowledge and experience of experts and other professionals in government, academia, and private industry, as well as its Board and Advisory Board members.